Top Insider Purchases of the Month -
100 results - 
- 
- 
- 
- 
- 
- - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2020-07-20 | BAC | Bank of America Corp /de/ | Berkshire Hathaway Inc | 10% | P - Purchase | $23.99 | +33,902,623 | 981,662,623 | +4% | +$813,327,610 | |||||
| M | 2020-07-28 | BAC | Bank of America Corp /de/ | Berkshire Hathaway Inc | 10% | P - Purchase | $24.65 | +21,180,716 | 1,019,267,705 | +2% | +$522,043,203 | |||||
| M | 2020-07-23 | BAC | Bank of America Corp /de/ | Berkshire Hathaway Inc | 10% | P - Purchase | $24.22 | +16,424,366 | 998,086,989 | +2% | +$397,865,938 | |||||
| M | 2020-07-31 | BAC | Bank of America Corp /de/ | Berkshire Hathaway Inc | 10% | P - Purchase | $24.81 | +13,584,301 | 1,032,852,006 | +1% | +$337,061,890 | |||||
2020-07-23 | VSAT | Viasat Inc | Baupost Group Llc/ma | 10% | P - Purchase | $39.11 | +2,556,891 | 16,288,959 | +19% | +$100,000,007 | ||||||
| D | 2020-07-14 | NKTX | Nkarta, Inc. | Ra Capital Management, L.P. | 10% | P - Purchase | $18.00 | +3,333,333 | 5,605,129 | +147% | +$59,999,994 | |||||
2008-03-11 | EMR | Emerson Electric Co | Aperture Technologies Inc | Dir | P - Purchase | $50.00 | +1,000,000 | 1,000,000 | New | +$50,000,000 | ||||||
| M | 2020-07-10 | WCC | Wesco International Inc | Green Equity Investors Vii, L.P. | 10% | P - Purchase | $35.78 | +962,805 | 3,087,281 | +45% | +$34,447,038 | |||||
| D | 2020-07-28 | ITOS | Iteos Therapeutics, Inc. | Boxer Capital, LLC | 10% | P - Purchase | $19.00 | +1,425,000 | 72,243 | -105% | +$27,075,000 | |||||
| D | 2020-07-28 | ITOS | Iteos Therapeutics, Inc. | Ra Capital Management, L.P. | 10% | P - Purchase | $19.00 | +1,425,000 | 4,417,259 | +48% | +$27,075,000 | |||||
| D | 2020-07-28 | ITOS | Iteos Therapeutics, Inc. | Davis Aaron I. | Dir, 10% | P - Purchase | $19.00 | +1,425,000 | 120,934 | -109% | +$27,075,000 | |||||
2020-07-14 | LCRDX | Lord Abbett Credit Opportunities Fund | Christina & Robert Dow Foundation | 10% | P - Purchase | $8.94 | +2,460,850 | 5,548,456 | +80% | +$22,000,000 | ||||||
2020-07-15 | DMS | Digital Media Solutions, Inc. | Lea Lyndon | Dir | P - Purchase | $9.36 | +2,000,000 | 2,000,000 | New | +$18,720,000 | ||||||
| D | 2020-07-21 | ALXO | Alx Oncology Holdings Inc | Vivo Capital Ix, LLC | 10% | P - Purchase | $19.00 | +975,000 | 185,526 | -123% | +$18,525,000 | |||||
| D | 2020-07-21 | ALXO | Alx Oncology Holdings Inc | Graham G. Walmsley | Dir | P - Purchase | $19.00 | +975,000 | 975,000 | New | +$18,525,000 | |||||
| M | 2020-07-31 | AXS | Axis Capital Holdings Ltd | Davis Charles A | Dir | P - Purchase | $40.57 | +450,000 | 2,915,853 | +18% | +$18,258,567 | |||||
| D | 2020-07-14 | NKTX | Nkarta, Inc. | Flynn James E | Possible Member of 10% Group, 10% | P - Purchase | $18.00 | +1,000,000 | 2,419,872 | +70% | +$18,000,000 | |||||
| D | 2020-07-21 | ALXO | Alx Oncology Holdings Inc | Adelman Robert J | See Remarks, 10% | P - Purchase | $19.00 | +853,000 | 5,829,542 | +17% | +$16,207,000 | |||||
| D | 2020-07-21 | ALXO | Alx Oncology Holdings Inc | Goodman Corey S | Executive Chairman, 10% | P - Purchase | $19.00 | +850,000 | 515,894 | -254% | +$16,150,000 | |||||
| D | 2020-07-14 | NKTX | Nkarta, Inc. | Glaxosmithkline Plc | Dir, 10% | P - Purchase | $18.00 | +833,333 | 3,150,732 | +36% | +$14,999,994 | |||||
2020-07-10 | AKRO | Akero Therapeutics, Inc. | Apple Tree Partners Iv, L.P. | 10% | P - Purchase | $36.00 | +415,000 | 5,830,203 | +8% | +$14,940,000 | ||||||
2020-07-10 | AKRO | Akero Therapeutics, Inc. | Harrison Seth Loring | Dir, 10% | P - Purchase | $36.00 | +415,000 | 5,830,203 | +8% | +$14,940,000 | ||||||
2020-07-09 | ALDX | Aldeyra Therapeutics, Inc. | Perceptive Advisors LLC | 10% | P - Purchase | $4.25 | +3,200,000 | 6,285,458 | +104% | +$13,600,000 | ||||||
| D | 2020-07-21 | PAND | Pandion Therapeutics, Inc. | Becker Daniel J. | Dir, 10% | P - Purchase | $18.00 | +723,222 | 2,601,773 | +38% | +$13,017,996 | |||||
| D | 2020-07-21 | PAND | Pandion Therapeutics, Inc. | Boxer Capital, LLC | 10% | P - Purchase | $18.00 | +722,222 | 2,131,135 | +51% | +$12,999,996 | |||||
| D | 2020-07-21 | PAND | Pandion Therapeutics, Inc. | Fuglesang Christopher | Dir, 10% | P - Purchase | $18.00 | +722,222 | 2,600,773 | +38% | +$12,999,996 | |||||
| D | 2020-07-14 | NKTK | Nkarta, Inc. | New Enterprise Associates 15, L.P. | 10% | P - Purchase | $18.00 | +666,666 | 2,902,115 | +30% | +$11,999,988 | |||||
| D | 2020-07-14 | NKTK | Nkarta, Inc. | Sandell Scott D | 10% | P - Purchase | $18.00 | +666,666 | 2,902,115 | +30% | +$11,999,988 | |||||
| D | 2020-07-14 | NKTK | Nkarta, Inc. | Sonsini Peter W. | 10% | P - Purchase | $18.00 | +666,666 | 2,902,115 | +30% | +$11,999,988 | |||||
| D | 2020-07-14 | NKTK | Nkarta, Inc. | Makhzoumi Mohamad | 10% | P - Purchase | $18.00 | +666,666 | 2,902,115 | +30% | +$11,999,988 | |||||
| D | 2020-07-14 | NKTK | Nkarta, Inc. | Baskett Forest | 10% | P - Purchase | $18.00 | +666,666 | 2,902,115 | +30% | +$11,999,988 | |||||
| D | 2020-07-14 | NKTK | Nkarta, Inc. | Makower Joshua | 10% | P - Purchase | $18.00 | +666,666 | 2,902,115 | +30% | +$11,999,988 | |||||
| D | 2020-07-14 | NKTK | Nkarta, Inc. | Florence Anthony A. Jr. | 10% | P - Purchase | $18.00 | +666,666 | 2,902,115 | +30% | +$11,999,988 | |||||
| D | 2020-07-28 | ANNX | Annexon, Inc. | Flynn James E | Possible Member of 10% Group, 10% | P - Purchase | $17.00 | +700,000 | 1,617,828 | +76% | +$11,900,000 | |||||
2020-07-23 | LCRDX | Lord Abbett Credit Opportunities Fund | Christina & Robert Dow Foundation | 10% | P - Purchase | $9.05 | +1,215,470 | 6,763,925 | +22% | +$11,000,000 | ||||||
| ADM | 2019-04-30 | KXIN | Kaixin Auto Holdings | Shareholder Value Fund | 10% | P - Purchase | $1.18 | +9,333,200 | 9,413,200 | >999% | +$10,989,381 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Longitude Capital Partners Iii, LLC | 10% | P - Purchase | $16.00 | +625,000 | 2,819,379 | +28% | +$10,000,000 | |||||
| D | 2020-07-14 | NKTX | Nkarta, Inc. | Novo Holdings A/s | 10% | P - Purchase | $18.00 | +555,555 | 2,793,865 | +25% | +$9,999,990 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Ra Capital Management, L.P. | 10% | P - Purchase | $16.00 | +600,000 | 2,003,653 | +43% | +$9,600,000 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Rock Springs Capital Management LP | 10% | P - Purchase | $16.00 | +600,000 | 1,067,884 | +128% | +$9,600,000 | |||||
2020-07-30 | FRG | Franchise Group, Inc. | Kahn Brian Randall | CEO, 10% | P - Purchase | $23.25 | +400,000 | 401,373 | >999% | +$9,300,000 | ||||||
2020-07-31 | ZMTP | Zoom Telephonics, Inc. | Zulu Holdings LLC | 10% | P - Purchase | $1.95 | +4,285,717 | 8,835,358 | +94% | +$8,357,148 | ||||||
2020-07-31 | ZMTP | Zoom Telephonics, Inc. | Hitchcock Jeremy P. | Exec COB, 10% | P - Purchase | $1.95 | +4,285,717 | 8,843,038 | +94% | +$8,357,148 | ||||||
2020-07-22 | CASI | Casi Pharmaceuticals, Inc. | He Wei-Wu | COB, CEO, 10% | P - Purchase | $1.90 | +4,152,426 | 12,809,942 | +48% | +$7,889,609 | ||||||
| D | 2020-07-21 | ALXO | Alx Oncology Holdings Inc | Lsv Associates, LLC | 10% | P - Purchase | $19.00 | +400,000 | 120,212 | -143% | +$7,600,000 | |||||
| D | 2020-07-21 | ALXO | Alx Oncology Holdings Inc | Lettmann Jason | Dir, 10% | P - Purchase | $19.00 | +400,000 | 227,432 | -232% | +$7,600,000 | |||||
2020-07-08 | ETNB | 89Bio, Inc. | Ra Capital Management, L.P. | Dir, 10% | P - Purchase | $27.50 | +275,000 | 3,436,214 | +9% | +$7,562,500 | ||||||
2020-07-08 | LCRDX | Lord Abbett Credit Opportunities Fund | Lord, Abbett & Co. LLC | Investment Adviser | P - Purchase | $9.01 | +835,547 | 957,448 | +685% | +$7,528,278 | ||||||
2020-07-28 | TTPH | Tetraphase Pharmaceuticals Inc | La Jolla Pharmaceutical Co | 10% | P - Purchase | $2.00 | +3,737,360 | 4,822,360 | +344% | +$7,474,720 | ||||||
| D | 2020-07-24 | GNCA | Genocea Biosciences, Inc. | Baskett Forest | 10% | P - Purchase | $2.25 | +3,151,260 | 10,376,936 | +44% | +$7,090,335 | |||||
| D | 2020-07-24 | GNCA | Genocea Biosciences, Inc. | New Enterprise Associates 16, L.P. | 10% | P - Purchase | $2.25 | +3,151,260 | 10,376,936 | +44% | +$7,090,335 | |||||
| D | 2020-07-24 | GNCA | Genocea Biosciences, Inc. | Walker Paul Edward | 10% | P - Purchase | $2.25 | +3,151,260 | 10,376,936 | +44% | +$7,090,335 | |||||
| D | 2020-07-24 | GNCA | Genocea Biosciences, Inc. | Sonsini Peter W. | 10% | P - Purchase | $2.25 | +3,151,260 | 10,376,936 | +44% | +$7,090,335 | |||||
| D | 2020-07-24 | GNCA | Genocea Biosciences, Inc. | Sandell Scott D | 10% | P - Purchase | $2.25 | +3,151,260 | 10,376,936 | +44% | +$7,090,335 | |||||
| D | 2020-07-24 | GNCA | Genocea Biosciences, Inc. | Makower Joshua | 10% | P - Purchase | $2.25 | +3,151,260 | 10,376,936 | +44% | +$7,090,335 | |||||
| D | 2020-07-24 | GNCA | Genocea Biosciences, Inc. | Makhzoumi Mohamad | 10% | P - Purchase | $2.25 | +3,151,260 | 10,376,936 | +44% | +$7,090,335 | |||||
| D | 2020-07-24 | GNCA | Genocea Biosciences, Inc. | Florence Anthony A. Jr. | 10% | P - Purchase | $2.25 | +3,151,260 | 10,376,936 | +44% | +$7,090,335 | |||||
| D | 2020-07-24 | GNCA | Genocea Biosciences, Inc. | Chang Carmen | 10% | P - Purchase | $2.25 | +3,151,260 | 10,376,936 | +44% | +$7,090,335 | |||||
| D | 2020-07-24 | GNCA | Genocea Biosciences, Inc. | Behbahani Ali | Dir, 10% | P - Purchase | $2.25 | +3,151,260 | 10,376,936 | +44% | +$7,090,335 | |||||
2020-08-05 | REKR | Rekor Systems, Inc. | Berman Robert Alan | CEO, 10% | P - Purchase | $2.57 | +2,725,836 | 6,084,940 | +81% | +$7,005,399 | ||||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Sofinnova Venture Partners X, L.P. | 10% | P - Purchase | $16.00 | +437,500 | 2,028,308 | +28% | +$7,000,000 | |||||
| D | 2020-07-28 | ANNX | Annexon, Inc. | Bain Capital Life Sciences Investors, LLC | 10% | P - Purchase | $17.00 | +400,000 | 3,241,628 | +14% | +$6,800,000 | |||||
2020-07-13 | TSE | Trinseo S.A. | M&g Investment Management Ltd | 10% | P - Purchase | $21.81 | +310,510 | 7,804,044 | +4% | +$6,772,223 | ||||||
| D | 2020-07-21 | PAND | Pandion Therapeutics, Inc. | Carroll Jill | Dir, 10% | P - Purchase | $18.00 | +361,111 | 2,248,304 | +19% | +$6,499,998 | |||||
| D | 2020-07-21 | PAND | Pandion Therapeutics, Inc. | Glaxosmithkline Plc | Dir, 10% | P - Purchase | $18.00 | +361,111 | 2,248,304 | +19% | +$6,499,998 | |||||
| D | 2020-07-21 | PAND | Pandion Therapeutics, Inc. | Ra Capital Management, L.P. | 10% | P - Purchase | $18.00 | +361,111 | 1,770,023 | +26% | +$6,499,998 | |||||
| D | 2020-07-28 | ITOS | Iteos Therapeutics, Inc. | Gadicke Ansbert | Dir, 10% | P - Purchase | $19.00 | +320,000 | 2,355,557 | +16% | +$6,080,000 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Novo Holdings A/s | 10% | P - Purchase | $16.00 | +375,000 | 2,569,379 | +17% | +$6,000,000 | |||||
| M | 2020-07-22 | OSG | Overseas Shipholding Group Inc | Saltchuk Resources, Inc. | 10% | P - Purchase | $2.48 | +2,187,058 | 14,115,798 | +18% | +$5,429,076 | |||||
2020-07-09 | CFOO | China Foods Holdings Ltd. | Kong Xiao Jun | CEO, CFO, 10% | P - Purchase | $0.32 | +13,950,000 | 18,951,000 | +279% | +$4,464,000 | ||||||
2020-07-28 | KMI | Kinder Morgan, Inc. | Kinder Richard D | Exec COB, 10% | P - Purchase | $14.14 | +300,000 | 256,713,346 | 0% | +$4,241,610 | ||||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Sonsini Peter W. | 10% | P - Purchase | $16.00 | +250,000 | 2,437,689 | +11% | +$4,000,000 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Sandell Scott D | 10% | P - Purchase | $16.00 | +250,000 | 2,437,689 | +11% | +$4,000,000 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Makower Joshua | 10% | P - Purchase | $16.00 | +250,000 | 2,437,689 | +11% | +$4,000,000 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Makhzoumi Mohamad | 10% | P - Purchase | $16.00 | +250,000 | 2,437,689 | +11% | +$4,000,000 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Florence Anthony A. Jr. | 10% | P - Purchase | $16.00 | +250,000 | 2,437,689 | +11% | +$4,000,000 | |||||
| D | 2020-07-14 | PSTX | Poseida Therapeutics, Inc. | Hirsch David | Dir | P - Purchase | $16.00 | +250,000 | 2,714,245 | +10% | +$4,000,000 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Baskett Forest | 10% | P - Purchase | $16.00 | +250,000 | 2,437,689 | +11% | +$4,000,000 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | New Enterprise Associates 15, L.P. | 10% | P - Purchase | $16.00 | +250,000 | 2,437,689 | +11% | +$4,000,000 | |||||
| D | 2020-07-10 | VCNX | Vaccinex, Inc. | Friedberg Albert | Dir, 10% | P - Purchase | $3.55 | +1,126,760 | 9,817,882 | +13% | +$3,999,998 | |||||
2020-07-29 | LCRDX | Lord Abbett Credit Opportunities Fund | Christina & Robert Dow Foundation | 10% | P - Purchase | $9.05 | +440,044 | 7,203,969 | +7% | +$3,982,398 | ||||||
2020-07-16 | EQS | Equus Total Return, Inc. | Hardy John A. | CEO, 10% | P - Purchase | $1.17 | +3,228,024 | 3,728,024 | +646% | +$3,776,788 | ||||||
| M | 2020-08-03 | EHTH | Ehealth, Inc. | Flanders Scott N | CEO | P - Purchase | $71.54 | +50,000 | 706,024 | +8% | +$3,576,874 | |||||
| M | 2020-08-03 | EVF | Eaton Vance Senior Income Trust | Saba Capital Management, L.P. | 10% | P - Purchase | $5.77 | +606,370 | 7,357,535 | +9% | +$3,498,703 | |||||
| D | 2020-07-28 | ANNX | Annexon, Inc. | Clarus Lifesciences Iii, L.P. | 10% | P - Purchase | $17.00 | +200,000 | 2,730,635 | +8% | +$3,400,000 | |||||
| D | 2020-07-28 | ANNX | Annexon, Inc. | Satter Muneer A | Dir | P - Purchase | $17.00 | +200,000 | 1,954,978 | +11% | +$3,400,000 | |||||
| D | 2020-07-28 | ITOS | Iteos Therapeutics, Inc. | Mpm Bioventures 2014, L.P. | 10% | P - Purchase | $19.00 | +160,000 | 25,974 | -119% | +$3,040,000 | |||||
| D | 2020-07-28 | ITOS | Iteos Therapeutics, Inc. | Mpm Bioventures 2014, L.P. | 10% | P - Purchase | $19.00 | +160,000 | 25,974 | -119% | +$3,040,000 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Pivotal Bioventure Partners Fund I, L.P. | 10% | P - Purchase | $16.00 | +187,500 | 1,591,154 | +13% | +$3,000,000 | |||||
| D | 2020-07-28 | INZY | Inozyme Pharma, Inc. | Hopfner Robert Lorne | Dir, 10% | P - Purchase | $16.00 | +187,500 | 1,591,154 | +13% | +$3,000,000 | |||||
2020-07-10 | ETNB | 89Bio, Inc. | Longitude Capital Partners Iii, LLC | 10% | P - Purchase | $27.50 | +109,090 | 2,600,877 | +4% | +$2,999,975 | ||||||
2020-07-10 | ETNB | 89Bio, Inc. | Grunberg Gregory | Dir, 10% | P - Purchase | $27.50 | +109,090 | 2,600,877 | +4% | +$2,999,975 | ||||||
2020-07-23 | T | At&t Inc. | Luczo Stephen J | Dir | P - Purchase | $29.69 | +100,000 | 300,000 | +50% | +$2,969,220 | ||||||
| D | 2020-07-24 | GNCA | Genocea Biosciences, Inc. | Glaxosmithkline Plc | 10% | P - Purchase | $2.25 | +1,260,504 | 4,626,389 | +37% | +$2,836,134 | |||||
2020-07-08 | CMCT | Cim Commercial Trust Corp | Kuba Shaul | Dir, 10% | P - Purchase | $25.00 | +106,518 | 106,518 | New | +$2,662,950 | ||||||
2020-07-08 | CMCT | Cim Commercial Trust Corp | Shemesh Avraham | Dir, 10% | P - Purchase | $25.00 | +106,518 | 106,518 | New | +$2,662,950 | ||||||
2020-07-08 | CMCT | Cim Commercial Trust Corp | Ressler Richard S | Dir, 10% | P - Purchase | $25.00 | +106,518 | 106,518 | New | +$2,662,950 | ||||||
2020-07-28 | GRCYU | Greencity Acquisition Corp | Cynthia Management Corp | 10% | P - Purchase | $10.00 | +260,000 | 1,410,000 | +23% | +$2,600,000 | ||||||
2020-07-28 | GRCYU | Greencity Acquisition Corp | Liu Jinlong | Dir | P - Purchase | $10.00 | +260,000 | 1,410,000 | +23% | +$2,600,000 | ||||||
2020-07-28 | GRCYU | Greencity Acquisition Corp | Yu Jianmin | CFO, 10% | P - Purchase | $10.00 | +260,000 | 1,410,000 | +23% | +$2,600,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |